Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

Published:2002-02 Issue:1 Volume:13 Page:41-59
ISSN:1359-6101
Container-title:Cytokine & Growth Factor Reviews
language:en
Short-container-title:Cytokine & Growth Factor Reviews

Author:

Maulik Gautam,Shrikhande Amol,Kijima Takashi,Ma Patrick C.,Morrison Paul T.,Salgia Ravi

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference126 articles.

1. Molecular cloning of a new transforming gene from a chemically transformed human cell line;Cooper;Nature,1984

2. Mechanism of met oncogene activation;Park;Cell,1986

3. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor–met signalling in human cells concomitant with induction of the urokinase proteolysis network;Jeffers;Mol. Cell Biol.,1996

4. Activating mutations for the met tyrosine kinase receptor in human cancer;Jeffers;Proc. Natl. Acad. Sci. USA,1997

5. The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization;Liu;Gene,1998

Cited by 353 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents;Journal of Molecular Structure;2024-12

2. c-MET is an important marker for acid-driven metastasis and anti-immune in colorectal cancer;International Immunopharmacology;2024-12

3. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

4. Aptamer-Based Enforced Phosphatase-Recruiting Chimeras Inhibit Receptor Tyrosine Kinase Signal Transduction;Journal of the American Chemical Society;2024-08-01

5. Aberrant MET Receptor Tyrosine Kinase Signaling in Glioblastoma: Targeted Therapy and Future Directions;Cells;2024-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3